The importance of basic and translational research in caring for children with malignant solid tumors in Latin America

被引:0
作者
Cancela, Maria Belen [1 ]
Dinardi, Milagros [1 ]
Aschero, Rosario [2 ]
Zugbi, Santiago [1 ]
Chantada, Guillermo [2 ]
Baroni, Lorena [3 ]
Schaiquevich, Paula [1 ]
机构
[1] Hosp Pediat JP Garrahan, Unidad Tratamientos Innovadores, Buenos Aires, Argentina
[2] Hosp St Joan de Deu, Pediat Canc Ctr Barcelona, Barcelona, Spain
[3] Hosp Pediat JP Garrahan, Serv Hematol Oncol, Buenos Aires, Argentina
来源
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH | 2024年 / 48卷
关键词
Malignant neoplasms; brain neoplasms; basic research; translational research; biomedical; Latin America; PATIENT-DERIVED XENOGRAFTS; CHILDHOOD-CANCER; RETINOBLASTOMA; OSTEOSARCOMA; COUNTRIES; PLATFORM; OUTCOMES; CARE; GAP;
D O I
10.26633/RPSP.2024.48
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. Basic and translational research in pediatric cancer are essential to improve patient care. To critically assess the developments achieved in these areas in Latin America, we systematically reviewed information published between 2013 and 2023. Methods. Studies of basic and translational research performed by investigators in Latin America evaluating pediatric malignant solid and central nervous system tumors were retrieved from PubMed. Original articles published in English between 2013 and 2023 were included. Collaborations among Latin American authors or among Latin American authors working with researchers from other continents were also included. Studies were excluded if they focused only on adults or on basic research in tumor biology not specifically related to the tumor types analyzed in this review. Results. A total of 550 articles were retrieved, but after removal of duplicates, 514 articles were included in the analysis, the majority of which were authored by researchers affiliated with institutions in Argentina, Brazil and Mexico. These countries also had the highest number of collaborations on original articles published with authors from Europe and North America. Argentina had the highest number of collaborations on original publications, with coauthors from Brazil and Uruguay. The median impact factor of the 244 journals in which articles were published was 3.5. The most commonly studied tumors were osteosarcomas, neuroblastomas and medulloblastomas; the most commonly studied areas were molecular analysis, tumor cell biology and biomarkers. Conclusions. In Latin America, research in pediatric oncology is on the agenda, despite a notable disparity in publication rates and frequency of collaboration between countries. There is a need to strengthen scientific collaboration within Latin America and with countries from other continents to promote research and to develop novel treatment strategies that reflect the local needs of children in Latin America who have solid tumors and brain cancer.
引用
收藏
页数:12
相关论文
共 49 条
  • [1] Alia DB, 2022, LANCET GLOB HEALTH, V10, pE1128, DOI 10.1016/S2214-109X(22)00250-9
  • [2] [Anonymous], 2024, National Childhood Cancer Registry Explorer: statistics in NCCR*- Explorer
  • [3] P2X7 receptor isoform B is a key drug resistance mediator for neuroblastoma
    Arnaud-Sampaio, Vanessa Fernandes
    Bento, Carolina Adriane
    Glaser, Talita
    Adinolfi, Elena
    Ulrich, Henning
    Lameu, Claudiana
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12
  • [4] Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma
    Aschero, Rosario
    Francis, Jasmine H.
    Ganiewich, Daiana
    Gomez-Gonzalez, Soledad
    Sampor, Claudia
    Zugbi, Santiago
    Ottaviani, Daniela
    Lemelle, Lauriane
    Mena, Marcela
    Winter, Ursula
    Llano, Genoveva Correa
    Lamas, Gabriela
    Lubieniecki, Fabiana
    Szijan, Irene
    Mora, Jaume
    Podhajcer, Osvaldo
    Doz, Francois
    Radvanyi, Francois
    Abramson, David H.
    Llera, Andrea S.
    Schaiquevich, Paula S.
    Lavarino, Cinzia
    Chantada, Guillermo L.
    [J]. CANCERS, 2021, 13 (04) : 1 - 15
  • [5] How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?
    Bailey, Simon
    Davidson, Alan
    Parkes, Jeannette
    Tabori, Uri
    Figaji, Anthony
    Epari, Shridar
    Chinnaswamy, Girish
    Dias-Coronado, Rosaldi
    Casavilca-Zambrano, Sandro
    Amayiri, Nisreen
    Vassal, Gilles
    Bouffet, Eric
    Clifford, Steven C.
    [J]. JCO GLOBAL ONCOLOGY, 2022, 8 : e2200156
  • [6] Bridging the treatment gap in infant medulloblastoma: molecularly informed outcomes of a globally feasible regimen
    Baroni, Lorena, V
    Sampor, Claudia
    Gonzalez, Adriana
    Lubieniecki, Fabiana
    Lamas, Gabriela
    Rugilo, Carlos
    Bartels, Ute
    Heled, Ayala
    Smith, Kyle S.
    Northcott, Paul A.
    Bouffet, Eric
    Alderete, Daniel
    Ramaswamy, Vijay
    [J]. NEURO-ONCOLOGY, 2020, 22 (12) : 1873 - 1881
  • [7] Molecular profiling of pediatric and adolescent ependymomas: identification of genetic variants using a next-generation sequencing panel
    Cabral de Carvalho Correa, Debora
    Tesser-Gamba, Francine
    Dias Oliveira, Indhira
    Saba da Silva, Nasjla
    Capellano, Andrea Maria
    de Seixas Alves, Maria Teresa
    Benevides Silva, Frederico Adolfo
    Dastoli, Patricia Alessandra
    Cavalheiro, Sergio
    Caminada de Toledo, Silvia Regina
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2021, 155 (01) : 13 - 23
  • [8] Expression of GNAS, TP53, and PTEN Improves the Patient Prognostication in Sonic Hedgehog (SHH) Medulloblastoma Subgroup
    da Silva, Luciane S.
    Mancano, Bruna M.
    de Paula, Flavia E.
    dos Reis, Mariana B.
    de Almeida, Gisele C.
    Matsushita, Marcus
    Junior, Carlos A.
    Evangelista, Adriane F.
    Saggioro, Fabiano
    Serafini, Luciano N.
    Stavale, Joao N.
    Malheiros, Suzana M. F.
    Lima, Matheus
    Hajj, Glaucia N. M.
    de Lima, Marcos A.
    Taylor, Michael D.
    Leal, Leticia F.
    Reis, Rui M.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (07) : 957 - 966
  • [9] de Lima RAG, 2023, Rev Lat Am Enfermagem, V31, P3998
  • [10] Induced resistance to ifosfamide in osteosarcoma cells suggests a more aggressive tumor profile
    de Oliveira Rodrigues, Maria Tereza
    da Silva, Lucas Pereira
    Pogue, Robert Edward
    de Carvalho, Juliana Lott
    Motoyama, Andrea Barretto
    Silva, Thuany de Alencar E.
    Sena Brunel, Hilana dos Santos
    Grossi de Sa, Maria Fatima
    de Andrade, Rosangela Vieira
    [J]. BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2022, 32